Delivery Order SPE2DB22D2206-SPE2DB24FFX64
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,567.60, is for the delivery of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product. The contract has a completion date of May 2, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite...
- This federal contract award, with a ceiling value of $29,612.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order for the supply of LYNPARZA 150 MG TABLET, a pharmaceutical product. This award is part of Amerisourcebergen Drug Corp's broader contract vehicle with DLA, an indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LYNPARZA 100 MG TABLET, a pharmaceutical product, with a ceiling value of $10,519.62 and a completion date of April 22, 2025. The contract is a Delivery Order under a Firm Fixed Price contract type. This award does not have a set-aside designation, indicating open competition....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,543.70 firm fixed-price delivery order is for the supply of LYNPARZA 100 MG TABLET UU 60S, a pharmaceutical product, with a performance period through July 24, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,567.60, is for the supply of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product. The contract has a firm-fixed price pricing type and an ultimate completion date of January 29, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor,...
- This is a $10,567.60 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product, with a period of performance through July 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,499.34, is for the delivery of LYNPARZA 150 MG TABLET UU 60S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside contract with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp is the prime contractor and holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LYNPARZA 150 MG TABLET UU 120S. The contract has a ceiling value of $42,438.84 and is a firm fixed price contract with a period of performance through June 3, 2025. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide the pharmaceutical product LYNPARZA 150 MG TABLET UU 120S. The contract has a ceiling value of $39,483.48 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of LYNPARZA 100 MG TABLET (4564376559) to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $49,023.90, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFX64Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of LYNPARZA 100 MG TABLET UU 120S, a pharmaceutical product. The contract is a firm fixed price delivery order with a potential value of $39,357.76 and a completion date of March 26, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.4k | 3/5/24 |